• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用功能磁共振成像检测弗里德赖希共济失调中难治性畏光症患者的视觉皮层异常活动。

Abnormal visual cortex activity using functional magnetic resonance imaging in treatment resistant photophobia in Friedreich Ataxia.

作者信息

Gunawardene Araliya N, Reyes Nicholas, Valdes-Arias David, Ortug Alpen, Martinez Jaime, Galor Anat, Moulton Eric A

机构信息

Ophthalmology, Miami Veterans Affairs Medical Center, 1201 NW 16 Street, Miami, FL, 33125, USA.

Bascom Palmer Eye Institute, University of Miami, 900 NW 17 Street, Miami, FL, 33136, USA.

出版信息

Am J Ophthalmol Case Rep. 2024 Nov 6;36:102213. doi: 10.1016/j.ajoc.2024.102213. eCollection 2024 Dec.

DOI:10.1016/j.ajoc.2024.102213
PMID:39583293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11585643/
Abstract

PURPOSE

Friedreich ataxia (FDRA) is a debilitating neurodegenerative disease that can have ophthalmological manifestations including visual dysfunction, nystagmus, and optic atrophy. However, severe photophobia has not been reported nor evaluated with functional magnetic resonance imaging (fMRI).

METHODS

A 64-year-old white female with a 37-year history of FDRA presented to the eye clinic with worsening photophobia of 3 years. To measure her visual cortex activation and subjective responses during episodes of photophobia, she underwent event-related fMRI with light stimuli. In comparison, the same protocol was conducted in an individual with photophobia but without FDRA. After the fMRI, both patients were treated with 35 units of BoNT-A applied to the forehead.

RESULTS

Analysis of visual cortex activity in response to light stimulus in the FDRA patient showed no correlation between blood oxygen level dependent (BOLD) activation and light stimuli in the first (r = -0.100, p = 0.235), and a weak negative correlation in the second half of the fMRI scan (r = -0.236 p = 0.004). In notable contrast, significant positive correlations were noted between visual cortex activity and the light stimulus (1st half: r = 0.742, p < 0.001, vs. 2nd half: r = 0.614, p < 0.001) in the comparator Six weeks later, no improvement in photophobia was noted in either patient.

CONCLUSION AND IMPORTANCE

Our study highlights photophobia as one potential ocular manifestation of FDRA and suggests that one underlying contributor may be a decoupled cortical neurovascular response to light. Our study provides novel information that may guide physiologic understanding and future treatments in this disease.

摘要

目的

弗里德赖希共济失调(FDRA)是一种使人衰弱的神经退行性疾病,可出现包括视觉功能障碍、眼球震颤和视神经萎缩在内的眼科表现。然而,严重畏光现象尚未见报道,也未通过功能磁共振成像(fMRI)进行评估。

方法

一名64岁白人女性,有37年FDRA病史,因畏光加重3年就诊于眼科门诊。为了测量她在畏光发作期间的视觉皮层激活情况和主观反应,她接受了光刺激事件相关fMRI检查。作为对照,对一名有畏光但无FDRA的个体进行了相同的检查。fMRI检查后,两名患者均在前额注射了35单位的肉毒杆菌毒素A(BoNT-A)。

结果

FDRA患者对光刺激的视觉皮层活动分析显示,在fMRI扫描的前半部分,血氧水平依赖(BOLD)激活与光刺激之间无相关性(r = -0.100,p = 0.235),而在后半部分存在弱负相关(r = -0.236,p = 0.004)。显著的是,在对照者中,视觉皮层活动与光刺激之间存在显著正相关(前半部分:r = 0.742,p < 0.001;后半部分:r = 0.614,p < 0.001)。六周后,两名患者的畏光症状均未改善。

结论与意义

我们的研究强调畏光是FDRA的一种潜在眼部表现,并表明一个潜在因素可能是皮层对光的神经血管反应解耦。我们的研究提供了新的信息,可能有助于对该疾病的生理理解和未来治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a263/11585643/7029a62868d2/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a263/11585643/62c15fa0e14d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a263/11585643/710b103d7bf4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a263/11585643/a0645f595a91/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a263/11585643/22168ed9bb84/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a263/11585643/7029a62868d2/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a263/11585643/62c15fa0e14d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a263/11585643/710b103d7bf4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a263/11585643/a0645f595a91/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a263/11585643/22168ed9bb84/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a263/11585643/7029a62868d2/gr5.jpg

相似文献

1
Abnormal visual cortex activity using functional magnetic resonance imaging in treatment resistant photophobia in Friedreich Ataxia.使用功能磁共振成像检测弗里德赖希共济失调中难治性畏光症患者的视觉皮层异常活动。
Am J Ophthalmol Case Rep. 2024 Nov 6;36:102213. doi: 10.1016/j.ajoc.2024.102213. eCollection 2024 Dec.
2
Pharmacological treatments for Friedreich ataxia.弗里德赖希共济失调的药物治疗
Cochrane Database Syst Rev. 2016 Aug 30;2016(8):CD007791. doi: 10.1002/14651858.CD007791.pub4.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Short-Term Memory Impairment短期记忆障碍
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Interventions for eye movement disorders due to acquired brain injury.针对后天性脑损伤所致眼球运动障碍的干预措施。
Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD011290. doi: 10.1002/14651858.CD011290.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.

本文引用的文献

1
Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.A型肉毒杆菌毒素可降低患有慢性眼痛和畏光症的个体中与疼痛相关脑区的神经活动。
Front Neurosci. 2023 Jun 19;17:1202341. doi: 10.3389/fnins.2023.1202341. eCollection 2023.
2
Clinical management guidelines for Friedreich ataxia: best practice in rare diseases.弗里德赖希共济失调临床管理指南:罕见病的最佳实践。
Orphanet J Rare Dis. 2022 Nov 12;17(1):415. doi: 10.1186/s13023-022-02568-3.
3
Clinical Neuroimaging of Photophobia in Individuals With Chronic Ocular Surface Pain.
慢性眼表疼痛患者畏光的临床神经影像学研究。
Am J Ophthalmol. 2023 Feb;246:20-30. doi: 10.1016/j.ajo.2022.09.020. Epub 2022 Oct 9.
4
Friedreich ataxia: clinical features and new developments.弗里德赖希共济失调:临床特征和新进展。
Neurodegener Dis Manag. 2022 Oct;12(5):267-283. doi: 10.2217/nmt-2022-0011. Epub 2022 Jun 29.
5
Functional MRI Studies in Friedreich's Ataxia: A Systematic Review.弗里德赖希共济失调的功能磁共振成像研究:一项系统综述
Front Neurol. 2022 Mar 10;12:802496. doi: 10.3389/fneur.2021.802496. eCollection 2021.
6
Neuro-Ophthalmological Findings in Friedreich's Ataxia.弗里德赖希共济失调的神经眼科表现
J Pers Med. 2021 Jul 23;11(8):708. doi: 10.3390/jpm11080708.
7
Alternative therapies for dry eye disease.干眼症的替代疗法。
Curr Opin Ophthalmol. 2021 Jul 1;32(4):348-361. doi: 10.1097/ICU.0000000000000768.
8
Exploring the Link Between Dry Eye and Migraine: From Eye to Brain.探索干眼与偏头痛之间的联系:从眼睛到大脑。
Eye Brain. 2021 Mar 4;13:41-57. doi: 10.2147/EB.S234073. eCollection 2021.
9
Future Prospects of Gene Therapy for Friedreich's Ataxia.弗里德里希共济失调的基因治疗的未来前景。
Int J Mol Sci. 2021 Feb 11;22(4):1815. doi: 10.3390/ijms22041815.
10
Botulinum Toxin: An Update on Pharmacology and Newer Products in Development.肉毒毒素:药理学最新进展及在研新产品
Toxins (Basel). 2021 Jan 14;13(1):58. doi: 10.3390/toxins13010058.